作者：
Siana,Nkya [1]
;
Josephine,Mgaya [2]
;
Florence,Urio [2]
;
Abel,Makubi [2]
;
Swee Lay,Thein [3]
;
Stephan,Menzel [4]
;
Sharon E,Cox [5]
;
Charles R,Newton [6]
;
Fenella J,Kirkham [7]
;
Bruno P,Mmbando [8]
;
Julie,Makani [6]
作者单位：
Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania; Dar-es-Salaam University College of Education, Dar-es-Salaam, Tanzania. Electronic address: siana.nkya@duce.ac.tz.
[1]
Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania.
[2]
King's College London, Molecular Haematology, Division of Cancer Studies, UK; Sickle Cell Branch, National Heart, Lung and Blood Institute, The National Institutes of Health, USA.
[3]
King's College London, Molecular Haematology, Division of Cancer Studies, UK.
[4]
Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania; Graduate School of Tropical Medicine & Global Health, Nagasaki University, Nagasaki, Japan; Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, London, UK.
[5]
Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania; Nuffield Department of Medicine, University of Oxford, UK.
[6]
UCL Great Oromnd Street Institute of Child Health, London, UK; Clinical and Experimental Sciences, University of Southampton, UK; Southampton Children's Hospital, UK.
[7]
Sickle Cell Programme, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania; National Institute for Medical Research, Tanga Centre, Tanga, Tanzania.
[8]
DOI
10.1016/j.ebiom.2017.08.006
PMID
28844412
发布时间
2022-04-08
换一批
换一批
